Stephen Scheeler

Omniscient Neurotechnology Pty Ltd., through its product infinitome, is revolutionizing the field of neurosurgery, neurology, and psychology by providing medical professionals with a better understanding of people's complex brain network data or 'connectomics'. The company is based in Sydney, Australia and was founded in 2018 by Michael Sughrue, Stephane Doyen. The Australian company's technology, Quicktome, is a neurosurgical planning platform that provides detailed, patient-specific knowledge of the brain's networks to enhance patient care. The Connectome Academy offers free courses on neuroscience, connectomic neurosurgery, and more. The CEO is Stephen Scheeler.

Omniscient Neurotechnology Pty Ltd., through its product infinitome, is revolutionizing the field of neurosurgery, neurology, and psychology by providing medical professionals with a better understanding of people's complex brain network data or 'connectomics'. The company is based in Sydney, Australia and was founded in 2018 by Michael Sughrue, Stephane Doyen. The Australian company's technology, Quicktome, is a neurosurgical planning platform that provides detailed, patient-specific knowledge of the brain's networks to enhance patient care. The Connectome Academy offers free courses on neuroscience, connectomic neurosurgery, and more. The CEO is Stephen Scheeler.

Omniscient Neurotechnology Pty Ltd., through its product infinitome, is revolutionizing the field of neurosurgery, neurology, and psychology by providing medical professionals with a better understanding of people's complex brain network data or 'connectomics'. The company is based in Sydney, Australia and was founded in 2018 by Michael Sughrue, Stephane Doyen. The Australian company's technology, Quicktome, is a neurosurgical planning platform that provides detailed, patient-specific knowledge of the brain's networks to enhance patient care. The Connectome Academy offers free courses on neuroscience, connectomic neurosurgery, and more. The CEO is Stephen Scheeler.

Omniscient Neurotechnology Pty Ltd., through its product infinitome, is revolutionizing the field of neurosurgery, neurology, and psychology by providing medical professionals with a better understanding of people's complex brain network data or 'connectomics'. The company is based in Sydney, Australia and was founded in 2018 by Michael Sughrue, Stephane Doyen. The Australian company's technology, Quicktome, is a neurosurgical planning platform that provides detailed, patient-specific knowledge of the brain's networks to enhance patient care. The Connectome Academy offers free courses on neuroscience, connectomic neurosurgery, and more. The CEO is Stephen Scheeler.

Omniscient Neurotechnology Pty Ltd., through its product infinitome, is revolutionizing the field of neurosurgery, neurology, and psychology by providing medical professionals with a better understanding of people's complex brain network data or 'connectomics'. The company is based in Sydney, Australia and was founded in 2018 by Michael Sughrue, Stephane Doyen. The Australian company's technology, Quicktome, is a neurosurgical planning platform that provides detailed, patient-specific knowledge of the brain's networks to enhance patient care. The Connectome Academy offers free courses on neuroscience, connectomic neurosurgery, and more. The CEO is Stephen Scheeler.